← Back
$SKYE All transactions

Skye Bioscience, Inc.

▼ SELL

$ Value

$209K

Shares

58,642

Price

$4

Filed

Aug 22

Insider

Name

Schwab Andrew J.

Title

CIK

0001598549

Roles

Director 10% Owner

Transaction Details

Transaction Date

2025-08-21

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

1,621,043

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.55 to $3.69 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The securities are directly held by 5AM Ventures II, L.P. ("Ventures II"). 5AM Partners II, LLC ("Partners II") is the sole general partner of Ventures II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. | The securities are directly held by 5AM Co-Investors II, L.P. ("Co-Investors II"). Partners II is the sole general partner of Co-Investors II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.30 to $3.59 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The securities are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. The Reporting Person is a managing member of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Filing Info

Accession No.

0001415889-25-022808

Form Type

4

Issuer CIK

0001516551

Schwab Andrew J.'s History

Date Ticker Type Value
2026-03-31 SKYE A $0
2025-09-11 CAMP A $4.5M
2025-08-22 SKYE $561K
2025-08-22 SKYE $22K
2025-08-21 SKYE $209K
2025-08-21 SKYE $8K
2025-06-25 CAMP A $0

Other Insiders at SKYE (90d)

Insider Bought Sold Last
DHILLON PUNIT
Chief Executive Officer
2026-03-31
Schwab Andrew J. 2026-03-31
Jenkins Annalisa 2026-03-31
Smith Karen L. 2026-03-31
Grayson Paul A. 2026-03-31
Twitty Christopher
Chief Scientific Officer
2026-03-31
Charych Deborah H. 2026-03-31
Diep Tuan Tu
Chief Operating Officer
2026-03-31